Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Ireland / NCT06454656
Recruiting Not applicable

A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy

NCT06454656 · tracked via the Priya Life Science Ireland tracker
Sponsor
Royal College of Surgeons, Ireland
Phase
Not applicable
Started
2024-08-12
Last updated
2026-04-14

Condition(s) studied

Cerebral PalsyWalking, DifficultySpastic DiplegiaHemiplegic Cerebral Palsy

Investigational drug(s) / intervention(s)

MOBILE

MOBILE: Intensive motor learning based intervention to target specific walking goals as identified using the Gait Outcome Assessment List. Full Protocol outlining strategies available on request. Three key principles underpin the intervention: Principle 1: The type of task Principle 2: The type of practice Principle 3: The type of Feedback

Study summary

The goal of this clinical trial is to learn if a new therapy approach to improve walking ability in children with Cerebral Palsy is acceptable to the children and the families in a community setting.

The main questions we look to answer are:

1. Do the children/teens tolerate the therapy and feel that it is helpful?
2. Do the parents/ families feel the therapy helps and is easy to commit to?
3. Do the children/teens complete all their therapy sessions and assessments as planned?

The participants will trial the therapy for 30 hours over 6 weeks and will perform assessments before and after to see if they meet their goals. They will also be interviewed to see how they felt about the therapy when they finish.

Eligibility

Sex
ALL
Min age
6 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Primary diagnosis of Cerebral Palsy (GMFCS Levels I-III) * Has a specific walking related goal * Has capacity to follow instruction * Has a primary caregiver who can support a home program Exclusion Criteria: * Has had surgery within 6 months of intervention start date * Has had botox/ baclofen within 3 months of intervention start date * Has a dual diagnosis that impacts ability to follow instruction * Has a significant cognitive impairment

Primary outcome measure(s)

  • Recruitment Rate — rolling recruitment over 1.5 years
    Percentage of eligible numbers recruited
  • Adherence to Intervention — Duration of study 2 years
    Percentage of total hours practiced/ planned dose (30 hours)
  • Retention — Duration of study 2 years
    Percentage of recruited participants at final follow up
  • Adverse Events — Duration of study 2 years
    Measured as Yes or No with description
  • Fidelity to Intervention Protocol — Duration of study 2 years
    Checklist to measure extent of motor learning principles included in sessions
  • Feasibility of Outcome Measures (Participant) — Duration of study 2 years
    Participant experience of outcomes captured by semi-structured interviews.
  • Feasibility of Outcome Measures (Assessor) — Duration of study 2 years
    Assessor experience of outcomes captured by semi-structured interview.
  • Acceptability of Intervention — Duration of study 2 years
    Semi-structured interviews of participants and parents to capture acceptability of intervention using Framework of acceptability
  • Time taken to complete Outcome Measures — Duration of study 2 years
    Measured in Minutes

Trial sites (1)

FacilityCityRegionStatus
Enable Ireland Bangla Therapy Centre Balrath Meath Recruiting

More Royal College of Surgeons, Ireland trials in Ireland

Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland Recruiting
The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep Inferior Epigastric Perforator (DIEP) Flap Reconstruction Surgery Recruiting
Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Primary Breast Cancer Recruiting
The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage Recruiting
ENVELOP: Wound Care Following Pilonidal Sinus Surgery Recruiting

Other trials for the same condition

Assessing Intellectual and Motor Outcomes in High-risk Infants Recruiting
Early Detection & Intervention of Cerebral Palsy in Ireland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06454656 on ClinicalTrials.gov ↗ ← All trials in Ireland